Oral preparation for analgesia, and preparation method of oral preparation

A technology for oral preparations and compositions, applied in the field of oral preparations and their preparation, can solve the problems of seriousness, addiction, gastrointestinal reactions, etc., and achieve the effects of reducing dosage, reducing toxic side effects, and improving stability
CN104095867AActive Publication Date: 2014-10-15DALIAN UNIVERSITY

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
DALIAN UNIVERSITY
Publication Date
2014-10-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of medicines, in particular to an oral preparation for analgesia, and a preparation method of the oral preparation. The oral preparation comprises a medicine composition and auxiliary materials, wherein the medicine composition comprises rosmarinic acid, tetrahydropalmatine, mangiferin and diclofenac sodium at a weight ratio of (2-4):(5-8):(3-6):(2-4); the auxiliary materials are preferably methyl cellulose, mannitol, aerosil and aspartame at a weight ratio of (200-400):(30-80):(30-60):(1-3); and a weight ratio of the medicine composition to the auxiliary materials is 1:(15-30).
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of medicines, in particular to an oral preparation for analgesia and a preparation method thereof. Background technique

[0002] Pain is a protective mechanism that alerts the body to the need for medical help. However, the loss of protective meaning of chronic pain has a heavy impact on people's lives. Clinically, at least half of the patients seek medical treatment because of pain. Existing analgesics are either ineffective, prone to serious adverse reactions, or both. For example, opioids can cause addiction, constipation, and respiratory depression; possible opioid abuse and drug dependence limit the use of these drugs. Non-steroidal anti-inflammatory drugs, COX-2 inhibitors, etc. have poor analgesic effects, and their application is limited because of many fatal and non-fatal adverse reactions. Therefore, it is very necessary and urgent to develop a drug that targets peripheral receptors and has strong analge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More